Should You Buy Strawberry Fields REIT, Inc. Stock in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Strawberry Fields REIT, Inc. (STRW) occupies a solid middle-ground position with a Quality of Company score of 7.0/10. At the current market price of $13.90, the investment case depends heavily on whether our 13 independent valuation models indicate a discount to fair value.
The short answer: 6 of 7 CirclFi valuation models project upside for Strawberry Fields REIT, Inc. (STRW) at $13.90 — the model consensus leans bullish, with a Quality Score of 7.0/10 and Value-Trap risk of 25/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.
What Is the Investment Case for Strawberry Fields REIT, Inc. (STRW) in 2026?
What Is the Bull Case vs the Bear Case for Strawberry Fields REIT, Inc. (STRW)?
| Bull case — $25.48 target (+83.3%) | Bear case — $4.79 target (-65.5%) |
|---|---|
| According to the CirclFi Quality of Company (QOC) framework, Strawberry Fields REIT, Inc.'s rating of 7.0/10 signals strong fundamentals — high-quality businesses tend to compound value more reliably. | According to the CirclFi Deep Alpha Valuation Engine, the Earnings Power Value (EPV) model sees the stock as overvalued with a fair value of $4.79 (-65.5%), suggesting that the market price embeds overly optimistic growth assumptions. |
| According to the CirclFi Deep Alpha Valuation Engine, 5 of 7 models identify upside from $13.90 to a median fair value of $17.44, indicating the market hasn't fully priced in Strawberry Fields REIT, Inc.'s earnings power. | According to the CirclFi Deep Alpha Valuation Engine, the wide model spread of +148.8% reflects fundamental divergence on key assumptions (growth, cost of capital) depending on the methodology. |
| According to the CirclFi Deep Alpha Valuation Engine, the Sentiment SOTP model targets a fair value of $25.48 (+83.3%), anchoring the bull case with a methodology that provides a differentiated analytical lens. | Industry headwind: generic/biosimilar competition represents a meaningful risk for Strawberry Fields REIT, Inc. and its REIT - Healthcare Facilities peers. |
| Industry tailwind: licensing and M&A optionality could provide meaningful support for Strawberry Fields REIT, Inc.'s revenue and margin trajectory in the REIT - Healthcare Facilities space. |
How Does STRW Compare to Its REIT - Healthcare Facilities Peers?
Valuation data pages: NHI · VTR · CHCT · HR · DOC · MPT · XRN · OHI · LTC · CTRE
Which Other Stocks Score Like STRW on Quality?
Closest companies to STRW’s Quality of Company score of 7.0/10, across all industries.
- VFC — V.F. Corporation (QOC 7.0) · analysis
- BWEN — Broadwind, Inc. (QOC 7.0) · analysis
- ZTG — Zenta Group Company Limited (QOC 7.0) · analysis
- ADTN — ADTRAN Holdings, Inc. (QOC 7.0) · analysis
- LITB — LightInTheBox Holding Co., Ltd. (QOC 7.0) · analysis
- ONDS — Ondas Inc. (QOC 7.0) · analysis
- NVDA — NVIDIA Corporation (QOC 10.0) · analysis
So Is Strawberry Fields REIT, Inc. (STRW) Worth Buying in 2026?
Strawberry Fields REIT, Inc. leans positive in our analysis — 5/7 models bullish, median fair value of $17.44 vs. $13.90, QOC 7.0/10. The case is constructive but not overwhelming, and the 1 dissenting model shouldn't be dismissed. Position sizing should reflect this moderate conviction level.
These are quantitative model outputs, not investment recommendations. Strawberry Fields REIT, Inc.'s future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →
What Else Do Investors Ask About STRW Stock?
Should I buy STRW stock right now?
Based on CirclFi's multi-model analysis, 6 of 7 models see upside for STRW at $13.90. The majority of models suggest the stock trades below fair value, but investors should weigh this against the Quality Score of 7.0/10 and individual risk tolerance. This is not a buy recommendation — see our full disclaimer.
What are the biggest risks of investing in Strawberry Fields REIT, Inc.?
Key risks include: limited model coverage (7/13 active), reducing analytical confidence; wide model disagreement (432% spread), signaling high uncertainty; general market and sector-specific risks affecting REIT - Healthcare Facilities companies. Always diversify and consult a financial advisor.
How does STRW compare to its competitors?
Among REIT - Healthcare Facilities peers, STRW holds a Quality Score of 7.0/10. Comparable companies include NHI (QOC 7.2), VTR (QOC 6.4), CHCT (QOC 7.2). The relative ranking helps investors identify whether STRW offers better fundamental quality than alternatives in the same sector.
Is STRW a good long-term investment?
Long-term investment potential depends on fundamental quality and sustainable competitive advantages. STRW's Quality Score of 7.0/10 is encouraging for long-term holders, indicating consistent profitability, manageable debt, and healthy cash flows. Check our full data page for all 13 model estimates.
What price should I buy STRW at?
CirclFi does not provide target buy prices or price alerts. However, our 7 active models produce fair value estimates ranging from $4.79 to $25.48. At $13.90, the stock trades within the range of model estimates. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.
Want the complete picture?
See all 13 model estimates, confidence scores, and the full valuation table for STRW.
Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →
Buy with Gumroad